Oprah Winfrey says the disappearance of so-called food noise is one of the most amazing effects of her GLP-1 drug. Plus now ...
A fitness enthusiast hurt her husband's feelings by telling him she likes "having a lil more to grab" after he gained weight.
Amanda Bynes detailed her nearly 30-lb. weight loss while using injectable type 2 diabetes drug Ozempic, and how it has ...
The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug. By Gina Kolata Gina Kolata has ...
Certain maneuvers allow you to exit from a highly appreciated stock position while delaying or avoiding the tax. But look closely at the drawbacks. How do you diversify away from a concentrated stock ...
The company will aim to enroll 50 cats in the study. A biopharmaceutical company is looking for ways to slim down household pets. Okava Pharmaceuticals, a San Francisco based company, plans to ...
We’ve all executed tax-loss harvesting. It’s a reactive strategy: We wait for a market dip and react by realizing losses to offset taxable income. If we’re doing our jobs right, however, our long-term ...
New research shows that women who halt GLP-1 medications near conception face greater gestational weight gain and elevated risks for preterm birth and pregnancy-related complications, raising urgent ...
Jillian Michaels shared her go-to rule for avoiding holiday weight gain. During an interview with Fox News Digital, the 51-year-old celebrity trainer explained that her secret to staying fit while ...
Jillian Michaels shared her go-to rule for avoiding holiday weight gain. During an interview with Fox News Digital, the 51-year-old celebrity trainer explained that her secret to staying fit while ...
The world has sounded off on Lizzo's weight, but now she's taking back the mic. The Grammy-winning singer-songwriter, whose appearance has been the subject of public scrutiny, opened up about her ...
An experimental medication was shown to help boost weight loss by up to 20%, a study found. Eloralintide, a once-weekly injectable manufactured by Eli Lilly in Indianapolis, led to "meaningful, ...